Literature DB >> 20347099

A novel mutation in GATA4 gene associated with dominant inherited familial atrial septal defect.

Yu Chen1, Zeng-Qiang Han, Wei-Dong Yan, Chu-Zhong Tang, Ji-Yan Xie, Hong Chen, Da-Yi Hu.   

Abstract

OBJECTIVE: Atrial septal defect (ASD) is a common congenital heart disease (CHD). Although most cases are sporadic, familial cases have been reported. The transcription factors NKX2.5 and GATA4 play important roles in the pathogenesis of ASD. Mutations in either gene have been identified in familial cases of ASD. Here, we examine a Chinese family with isolated ASD to find out whether there is any mutation in NKX2.5 or GATA4 accounting for the etiology.
METHODS: We identified kindred spanning 3 generations in which 8 of 31 (38%) individuals had ASD. One hundred seventy unrelated individuals were included as controls. Peripheral blood samples were collected and genomic DNA was extracted from the leukocytes. NKX2.5 and GATA4 were amplified by polymerase chain reaction (PCR) with specific primers. The sequences of PCR products were compared between affected members and unaffected members, as well as controls.
RESULTS: Direct sequencing of NKX2.5 from the genomic DNA of family members failed to identify mutations, whereas sequencing of GATA4 identified an A-to-G transition at nucleotide 928 in exon 5 that predicted a methionine to valine substitution at codon 310 (M310V) in the NLS region. All affected members and a patriarch of the family who was recognized as a carrier exhibited this mutation, whereas the other unaffected family members or control individuals did not. This mutation has not been reported previously in either familial or sporadic cases of CHD.
CONCLUSIONS: We identified a novel M310V mutation in GATA4 gene that is located in the NLS region and leads to hereditary ASD in a Chinese family. In this family, we identified a carrier with incomplete penetrance and 8 patients with variable expressivity. However, the mechanism by which this mutation contributes to the development of a congenital heart defect remains to be ascertained. 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347099     DOI: 10.1016/j.jtcvs.2010.01.013

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

Review 3.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

4.  A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect.

Authors:  Yi-Qing Yang; Li Li; Juan Wang; Xing-Yuan Liu; Xiao-Zhong Chen; Wei Zhang; Xiao-Zhou Wang; Jin-Qi Jiang; Xu Liu; Wei-Yi Fang
Journal:  Pediatr Cardiol       Date:  2011-11-20       Impact factor: 1.655

Review 5.  Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders.

Authors:  Terence Prendiville; Patrick Y Jay; William T Pu
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

6.  Genetic counseling in the adult with congenital heart disease: what is the role?

Authors:  Luke Burchill; Steven Greenway; Candice K Silversides; Seema Mital
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

7.  GATA4 transgenic mice as an in vivo model of congenital heart disease.

Authors:  Hua Han; Yu Chen; Gang Liu; Zengqiang Han; Zhou Zhao; Yin Tang
Journal:  Int J Mol Med       Date:  2015-04-09       Impact factor: 4.101

8.  Mutation spectrum of GATA4 associated with congenital atrial septal defects.

Authors:  Yi-Qing Yang; Juan Wang; Xing-Yuan Liu; Xiao-Zhong Chen; Wei Zhang; Xiao-Zhou Wang
Journal:  Arch Med Sci       Date:  2013-12-26       Impact factor: 3.318

9.  Congenital heart disease: the crossroads of genetics, epigenetics and environment.

Authors:  Cecilia Vecoli; Silvia Pulignani; Ilenia Foffa; Maria Grazia Andreassi
Journal:  Curr Genomics       Date:  2014-10       Impact factor: 2.236

10.  Atrial ERK1/2 activation in the embryo leads to incomplete Septal closure: a novel mouse model of atrial Septal defect.

Authors:  Che-Chung Yeh; Yanying Fan; Yi-Lin Yang; Michael J Mann
Journal:  J Biomed Sci       Date:  2017-11-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.